Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
PLoS One ; 11(8): e0161058, 2016.
Article in English | MEDLINE | ID: mdl-27529551

ABSTRACT

INTRODUCTION: Surgical site infections (SSI) are a serious complication in vascular surgery which may lead to severe morbidity and mortality. Staphylococcus aureus nasal carriage is associated with increased risk for development of SSIs in central vascular surgery. The risk for SSI can be reduced by perioperative eradication of S. aureus carriage in cardiothoracic and orthopedic surgery. This study analyzes the relation between S. aureus eradication therapy and SSI in a vascular surgery population. METHODS: A prospective cohort study was performed, including all patients undergoing vascular surgery between February 2013 and April 2015. Patients were screened for S. aureus nasal carriage and, when tested positive, were subsequently treated with eradication therapy. The presence of SSI was recorded based on criteria of the CDC. The control group consisted of a cohort of vascular surgery patients in 2010, who were screened, but received no treatment. RESULTS: A total of 444 patients were screened. 104 nasal swabs were positive for S. aureus, these patients were included in the intervention group. 204 patients were screened in the 2010 cohort. 51 tested positive and were included in the control group. The incidence of S. aureus infection was 5 out of 51 (9.8%) in the control group versus 3 out of 104 in the eradication group (2.2%; 95% confidence interval 0.02-1.39; P = 0.13). A subgroup analysis showed that the incidence of S. aureus infection was 3 out of 23 (13.0%) in the control group in central reconstructive surgery versus 0 out of 44 in the intervention group (P = 0.074). The reduction of infection pressure by S. aureus was stronger than the reduction of infection pressure by other pathogens (exact maximum likelihood estimation; OR = 0.0724; 95% CI: 0.001-0.98; p = 0.0475). CONCLUSION: S. aureus eradication therapy reduces the infection pressure of S. aureus, resulting in a reduction of SSIs caused by S. aureus.


Subject(s)
Staphylococcal Infections/prevention & control , Staphylococcus aureus/drug effects , Staphylococcus aureus/physiology , Surgical Wound Infection/prevention & control , Vascular Surgical Procedures/adverse effects , Aged , Female , Humans , Male , Nose/microbiology , Staphylococcus aureus/isolation & purification
2.
Epidemiol Infect ; 144(8): 1774-83, 2016 06.
Article in English | MEDLINE | ID: mdl-26733049

ABSTRACT

There is limited knowledge about the effect of livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) carriage on health-related quality of life (QoL). With this study, we explored whether LA-MRSA causes infections or affects health-related QoL in pig farmers. This prospective cohort study surveyed persons working on 49 farrowing pig farms in The Netherlands for 1 year (2010-2011). On six sampling moments, nasal swabs, environmental samples and questionnaires on activities and infections were collected. At the end of the study year, persons were asked about their QoL using the validated SF-36 and EQ-5D questionnaires. Of 120 persons, 44 (37%) were persistent MRSA carriers. MRSA carriage was not associated with infections, use of antimicrobials, healthcare contact and health-related QoL items in univariate or multivariate analysis, most likely due to the 'healthy worker effect'. Despite high carriage rates, the impact of LA-MRSA carriage in this population of relatively healthy pig farmers on health and health-related QoL appears limited; more research is needed for confirmation.


Subject(s)
Carrier State/epidemiology , Carrier State/microbiology , Farmers , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Quality of Life , Staphylococcal Infections/epidemiology , Staphylococcal Infections/microbiology , Adult , Animal Husbandry , Animals , Environmental Microbiology , Female , Humans , Male , Middle Aged , Nasal Mucosa/microbiology , Netherlands/epidemiology , Prospective Studies , Surveys and Questionnaires , Swine
3.
Infection ; 43(6): 747-50, 2015 Dec.
Article in English | MEDLINE | ID: mdl-25764306

ABSTRACT

We describe a 26-year-old otherwise healthy woman with MRSA vaginitis. Traditional MRSA risk factors were absent and additional screening sites were negative. Patient was treated successfully with oral antibiotics combined with topical lactic acid emulsion. Because her partner appeared to have solitary MRSA carriage on the glans, a suggestion of sexual transmission was made. He was treated successfully with topical mupirocin ointment. Although solitary vaginal MRSA carriage and infection seems to be rare and its clinical impact is yet undefined, clinicians should consider adding the genitourinary tract to traditional screening sites in case of recurrent MRSA infections.


Subject(s)
Methicillin-Resistant Staphylococcus aureus/isolation & purification , Staphylococcal Infections/diagnosis , Staphylococcal Infections/microbiology , Vaginitis/diagnosis , Vaginitis/microbiology , Administration, Intravaginal , Administration, Oral , Adult , Anti-Bacterial Agents/administration & dosage , Female , Humans , Lactic Acid/administration & dosage , Treatment Outcome
4.
Ned Tijdschr Geneeskd ; 158: A6812, 2014.
Article in Dutch | MEDLINE | ID: mdl-24548593

ABSTRACT

BACKGROUND: Community-acquired infection with methicillin-resistant Staphylococcus aureus (CA-MRSA) mainly affects healthy young people, without health-care related risk factors for MRSA. Patients often present with skin and soft-tissue infections. CASE DESCRIPTION: An 18-year-old woman presented at the casualty department with recurrent purulent skin infections. She proved to be MRSA-positive. Within 6 months, 2 people around her also developed an MRSA infection. Culture showed CA-MRSA, with an identical strain (spa type: t008). Additional screening within her immediate circle identified 4 carriers, 2 of whom had corresponding skin infections. CONCLUSION: Cluster outbreaks of CA-MRSA require a coordinated approach from both the treating physician and the public health services. The choice of additional investigation among the circle of contacts was the determining factor in breaking the cycle of transmission and reinfection within this cluster.


Subject(s)
Community-Acquired Infections/epidemiology , Methicillin-Resistant Staphylococcus aureus , Staphylococcal Skin Infections/epidemiology , Adolescent , Community-Acquired Infections/diagnosis , Community-Acquired Infections/transmission , Disease Outbreaks , Female , Humans , Risk Factors , Staphylococcal Skin Infections/diagnosis , Staphylococcal Skin Infections/transmission , United States
5.
Clin Microbiol Infect ; 16(12): 1754-61, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20219077

ABSTRACT

Pre-emptive isolation of suspected methicillin-resistant Staphylococcus aureus (MRSA) carriers is considered essential for controlling the spread of MRSA, but noncolonized patients will be isolated unnecessarily as a result of a delay in diagnosis of 3-5 days with conventional cultures. We determined costs per isolation day avoided, and incremental costs of rapid MRSA screening tests when added to conventional screening, but with decisions on isolation measures based on PCR results. A prospective multicentre study evaluating BD GeneOhm MRSA PCR (`IDI') (BD Diagnostics, San Diego, CA, USA), Xpert MRSA (`GeneXpert') (Cepheid, Sunnyvale, CA, USA) and chromogenic agar (MRSA-ID) (bioMérieux, Marcy-l'Etoile, France) was performed in 14 Dutch hospitals. Among 1764 patients at risk, MRSA prevalence was 3.3% (n=59). Duration of isolation was 19.7 and 16.1 h with IDI and GeneXpert, respectively, and would have been 30.0 and 76.2 h when based on chromogenic agar and conventional cultures, respectively. Negative predictive values (at a patient level) were 99.5%, 99.1% and 99.5% for IDI, GeneXpert and chromogenic agar, respectively. Numbers of isolation days were reduced by 60% and 47% with PCR-based and chromogenic agar-based screening, respectively. The cost per test was €56.22 for IDI, €69.62 for GeneXpert and €2.08 for chromogenic agar, and additional costs per extra isolation day were €26.34. Costs per isolation day avoided were €95.77 (IDI) and €125.43 (GeneXpert). PCR-based decision-making added €153.64 (IDI) and €193.84 (GeneXpert) per patient to overall costs and chromogenic testing would have saved €30.79 per patient. Rapid diagnostic testing safely reduces the number of unnecessary isolation days, but only chromogenic screening, and not PCR-based screening, can be considered as cost saving.


Subject(s)
Carrier State/diagnosis , Health Care Costs , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Patient Isolation/economics , Polymerase Chain Reaction/economics , Staphylococcal Infections/diagnosis , Agar , Carrier State/economics , Carrier State/microbiology , Chromogenic Compounds , Cost-Benefit Analysis , Cross Infection , Diagnostic Tests, Routine , Humans , Polymerase Chain Reaction/methods , Predictive Value of Tests , Prospective Studies , Staphylococcal Infections/economics , Staphylococcal Infections/microbiology
6.
J Hosp Infect ; 72(4): 299-306, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19596488

ABSTRACT

The application of the search and destroy (S&D) policy in Scandinavian and Dutch hospitals is associated with low rates of meticillin-resistant Staphylococcus aureus (MRSA). The objective of our study was to describe the MRSA epidemiology and transmission in a Dutch hospital. This descriptive study was performed in a teaching hospital with approximately 40,000 admissions per year. In this hospital the MRSA S&D policy has been applied for several decades. MRSA epidemiology was studied during the years 2001 to 2006. The transmission rate in this hospital was determined using (1) patient's history, (2) relation in time and place to other patients or healthcare workers (HCWs), and (3) molecular typing (pulsed-field gel electrophoresis and Spa). Ninety-five persons were identified as MRSA carriers, namely 82 patients and 13 HCWs. The annual MRSA incidence increased more than three-fold during the study period, which was entirely caused by animal-related MRSA. Twenty-three percent of the patients acquired MRSA in a foreign hospital, 26% via animals, 16% by nosocomial transmission, 4% in another Dutch healthcare institution, 10% in the community via a known MRSA-positive person, and in 22% the source was unknown. For HCWs, 69% of MRSA was due to nosocomial transmission, 15% was related to working in a foreign hospital and in 15% HCWs became colonised via an MRSA-positive partner or relative. The transmission rate of 0.30 (22 secondary cases from 73 index cases) indicates that the spread of MRSA was under control during the study period, and so the S&D policy should be continued.


Subject(s)
Community-Acquired Infections/epidemiology , Community-Acquired Infections/microbiology , Cross Infection/epidemiology , Cross Infection/microbiology , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Staphylococcal Infections/epidemiology , Staphylococcal Infections/microbiology , Adult , Animals , Bacterial Typing Techniques/methods , Carrier State/epidemiology , Carrier State/microbiology , Cluster Analysis , Cross Infection/transmission , DNA Fingerprinting/methods , DNA, Bacterial/genetics , Electrophoresis, Gel, Pulsed-Field/methods , Female , Genotype , Hospitals, Teaching , Humans , Male , Methicillin-Resistant Staphylococcus aureus/classification , Methicillin-Resistant Staphylococcus aureus/genetics , Middle Aged , Molecular Epidemiology , Netherlands/epidemiology , Staphylococcal Infections/transmission
7.
Eur J Clin Microbiol Infect Dis ; 28(10): 1245-52, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19618223

ABSTRACT

The objective of this study was to determine the costs and benefits of the MRSA Search and Destroy policy in a Dutch hospital during 2001 through 2006. Variable costs included costs for isolation, contact tracing, treatment of carriers and closure of wards. Fixed costs were the costs for the building of isolation rooms and the salary of one full-time infection control practitioner. To determine the benefits of the Search and Destroy policy, the transmission rate during the study period was calculated. Furthermore, the number of cases of meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia prevented was estimated, as well as its associated prevented costs and patient lives. The costs of the MRSA policy were estimated to be euro 215,559 a year, which equals euro 5.54 per admission. The daily isolation costs for MRSA-suspected and -positive hospitalised patients were euro 95.59 and euro 436.62, respectively. Application of the Search and Destroy policy resulted in a transmission rate of 0.30 and was estimated to prevent 36 cases of MRSA bacteraemia per year, resulting in annual savings of euro 427,356 for the hospital and ten lives per year (95% confidence interval [CI] 8-14). In conclusion, application of the MRSA Search and Destroy policy in a hospital in a country with a low endemic MRSA incidence saves money and lives.


Subject(s)
Cross Infection/economics , Cross Infection/prevention & control , Hospital Costs , Infection Control/economics , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Staphylococcal Infections/economics , Staphylococcal Infections/prevention & control , Anti-Bacterial Agents/economics , Anti-Bacterial Agents/therapeutic use , Bacteremia/economics , Bacteremia/prevention & control , Carrier State/economics , Contact Tracing/economics , Cost-Benefit Analysis , Disease Outbreaks/prevention & control , Health Facility Closure/economics , Health Policy/economics , Humans , Infection Control/methods , Infection Control Practitioners/economics , Netherlands , Staphylococcal Infections/epidemiology , Staphylococcal Infections/transmission
SELECTION OF CITATIONS
SEARCH DETAIL
...